The Rundown: DeepMind just revealed an update to AlphaFold 2, which can now predict structures of diverse molecules beyond proteins — unlocking new drug discovery capabilities.
AlphaFold can now predict 3D structures for nearly all cataloged molecules in biology — including DNA, RNA, and small molecules.
The update unlocks a new understanding of complex systems like protein interactions, cell signaling pathways, and genome editing tools.
Researchers anticipate AlphaFold’s upgrade has the potential to rapidly advance disease research, drug development, synthetic biology, and other scientific fields.
Why it matters: Each AlphaFold iteration brings more astonishing progress — propelling fields like drug discovery forward at astonishing speeds. Will AI help lead to a new era of medicine and disease prevention?
The Rundown: Quora's AI chatbot platform Poe just introduced a revenue-sharing program to pay bot creators when their bots lead to app subscriptions.
Bot creators earn up to $20 per monthly subscription or $10 per annual subscription resulting from a user engaging with their bot.
Creators can soon set per-message fees that Poe will pay out for each user interaction, providing recurring revenue.
The program aims to incentivize developers and researchers to build differentiated bots that drive new users to Poe.
The move follows the rise of lucrative creator economies on social platforms — and could expand to other AI assistant apps.
Our thoughts: Monetizing AI creators is a smart move as chatbot platforms compete for differentiated offerings. Hopefully, equitable revenue-sharing models eventually become an industry norm to further incentivize creators.
QUESTION OF THE DAY
🤖 Which world-altering breakthrough happens first with AI?
Researchers just trained an AI to spot type 2 diabetes from subtle vocal clues, analyzing pitch and intensity to diagnose patients in just seconds. This type of voice-based screening could greatly expand access and affordability.
Shield AI, the maker of AI drone pilots, just raised $200M at a $2.7B valuation — with the massive round building on its $60M raise in 2021. Investor appetite for defense AI is seemingly growing despite some ethical squeamishness from the public regarding the tech’s use in warfare.
Google Brain co-founder Andrew Ng accused tech giants of overblowing AI extinction scenarios to spur regulation in a recent interview with the Australian Financial Review. The AI visionary believes large players want stricter rules to crush open-source rivals and avoid competition.